Merck

855675P

Avanti

16:0 リゾPC

Avanti Polar Lipids

ログインto View Organizational & Contract Pricing

別名:
1-ヘキサデカノイル-sn-グリセロ-3-ホスホコリン、PC(16:0/0:0)
Empirical Formula (Hill Notation):
C24H50NO7P
CAS番号:
分子量:
495.63
NACRES:
NA.25

詳細

1-palmitoyl-2-hydroxy-sn-glycero-3-phosphocholine

アッセイ

>99% (LPC; may contain up to 10% of the 2-LPC isomer, TLC)

形状

powder

包装

pkg of 1 × 1 g (855675P-1g)
pkg of 1 × 200 mg (855675P-200mg)
pkg of 1 × 25 mg (855675P-25mg)
pkg of 1 × 500 mg (855675P-500mg)

manufacturer/tradename

Avanti Polar Lipids

輸送温度

dry ice

保管温度

−20°C

SMILES string

O[C@](COP([O-])(OCC[N+](C)(C)C)=O)([H])COC(CCCCCCCCCCCCCCC)=O

InChI

1S/C24H50NO7P/c1-5-6-7-8-9-10-11-12-13-14-15-16-17-18-24(27)30-21-23(26)22-32-33(28,29)31-20-19-25(2,3)4/h23,26H,5-22H2,1-4H3/t23-/m1/s1

InChI key

ASWBNKHCZGQVJV-HSZRJFAPSA-N

類似品目との比較

比較内容をすべて表示

相違点を表示

1 of 4

当該品目
855675C855575P855775P
16:0 Lyso PC Avanti Polar Lipids

Avanti

855675P

16:0 リゾPC

16:0 Lyso PC 1-palmitoyl-2-hydroxy-sn-glycero-3-phosphocholine, chloroform

Avanti

855675C

16:0 Lyso PC

14:0 Lyso PC 1-myristoyl-2-hydroxy-sn-glycero-3-phosphocholine, powder

Avanti

855575P

14:0 リゾPC

18:0 Lyso PC Avanti Polar Lipids

Avanti

855775P

18:0 リゾPC

form

powder

form

liquid

form

powder

form

powder

packaging

pkg of 1 × 1 g (855675P-1g), pkg of 1 × 200 mg (855675P-200mg), pkg of 1 × 25 mg (855675P-25mg), pkg of 1 × 500 mg (855675P-500mg)

packaging

pkg of 1 × 2.5 mL (855675C-25mg), pkg of 2 × 4 mL (855675C-200mg)

packaging

pkg of 1 × 1 g (855575P-1g), pkg of 1 × 200 mg (855575P-200mg), pkg of 1 × 25 mg (855575P-25mg), pkg of 1 × 500 mg (855575P-500mg)

packaging

pkg of 1 × 1 g (855775P-1g), pkg of 1 × 200 mg (855775P-200mg), pkg of 1 × 25 mg (855775P-25mg), pkg of 1 × 500 mg (855775P-500mg)

manufacturer/tradename

Avanti Polar Lipids

manufacturer/tradename

Avanti Polar Lipids 855675C

manufacturer/tradename

Avanti Polar Lipids 855575P

manufacturer/tradename

Avanti Polar Lipids

shipped in

dry ice

shipped in

dry ice

shipped in

dry ice

shipped in

dry ice

storage temp.

−20°C

storage temp.

−20°C

storage temp.

−20°C

storage temp.

−20°C

包装

20mL透明ガラス製ねじ蓋バイアル(855675P-1g)
20mL透明ガラス製ねじ蓋バイアル(855675P-500mg)
5mL琥珀色ガラス製ねじ蓋バイアル(855675P-200mg)
5mL琥珀色ガラス製ねじ蓋バイアル(855675P-25mg)

保管分類コード

11 - Combustible Solids

WGK

WGK 3

引火点(°F)

Not applicable

引火点(℃)

Not applicable


試験成績書(COA)

製品のロット番号・バッチ番号を入力して、試験成績書(COA) を検索できます。ロット番号・バッチ番号は、製品ラベルに「Lot」または「Batch」に続いて記載されています。

Already Own This Product?

Documents related to the products that you have purchased in the past have been gathered in the Document Library for your convenience.

Visit the Document Library

Difficulty Finding Your Product Or Lot/Batch Number?

ウェブサイトの表示では、製品番号に容量/数量が連結しています(例:T1503-25G)。確認してください 製品番号欄には製品番号のみを入力してください (: T1503).

T1503
製品番号
-
25G
容量/数量

その他の例:

705578-5MG-PW

PL860-CGA/SHF-1EA

MMYOMAG-74K-13

1000309185

以下のように入力してください 1.000309185)

ご不明な点がございましたら、お気軽にお問い合わせくださいテクニカルサービス お問い合わせ

ロット番号とバッチ番号は、製品ラベルで「Lot」または「Batch」の言葉に続いて記載されています。

Aldrich製品

  • もしTO09019TOなどのロット番号を見つけた場合は、最初の2文字を除いたロット番号09019TOを入力します。

  • もし05427ES-021などの充てんコード付きロット番号を見つけた場合は、充てんコードの-021を除いたロット番号05427ESを入力します。

  • もしSTBB0728K9などの充てんコード付きロット番号を見つけた場合は、充てんコードのK9を除いたロット番号STBB0728を入力します。

お探しのものが見つかりませんか?

オンラインでCOAを入手できない場合があります。検索してもCOAが見つからない場合は、リクエストできます。

COAをリクエストする

この製品を見ている人はこちらもチェック

Slide 1 of 10

1 of 10

2-16:0 Lyso PC Avanti Polar Lipids

Avanti

855674P

2-16:0 Lyso PC

17:0 Lyso PC Avanti Polar Lipids

Avanti

855676P

17:0 リゾPC

18:1 Lyso PC 1-oleoyl-2-hydroxy-sn-glycero-3-phosphocholine, chloroform

Avanti

845875C

18:1 リゾPC

16:0 Lyso PG 1-palmitoyl-2-hydroxy-sn-glycero-3-phospho-(1′-rac-glycerol) (sodium salt), powder

Avanti

858122P

16:0 リゾPG

16:0 lyso PC-d49 powder

Avanti

870308P

16:0 lyso PC-d49

2-18:0 Lyso PC Avanti Polar Lipids 855774P, powder

Avanti

855774P

2-18:0 Lyso PC

16:0 Lyso PI 1-palmitoyl-2-hydroxy-sn-glycero-3-phosphoinositol (ammonium salt), powder

Avanti

850102P

16:0リゾPI

18:0 Lyso PE 1-Stearoyl-2-Hydroxy-sn-Glycero-3-Phosphoethanolamine, powder

Avanti

856715P

18:0リゾPE

18:1 Lyso PS Avanti Polar Lipids

Avanti

858143P

18:1リゾPS

Egg Lyso PC Avanti Polar Lipids 830071P, powder

Avanti

830071P

卵リゾPC

Xinyuan Li et al.
Redox biology, 28, 101373-101373 (2019-11-16)
It has been shown that anti-inflammatory cytokines interleukin-35 (IL-35) and IL-10 could inhibit acute endothelial cell (EC) activation, however, it remains unknown if and by what pathways IL-35 and IL-10 could block atherogenic lipid lysophosphatidylcholine (LPC)-induced sustained EC activation; and
Takafumi Enomoto et al.
Langmuir : the ACS journal of surfaces and colloids, 34(3), 750-755 (2017-10-06)
A major goal of synthetic biology is the development of rational methodologies to construct self-assembling non-natural membranes, which could enable the efficient fabrication of artificial cellular systems from purely synthetic components. However, spatiotemporal control of artificial membrane formation remains both
Li V Yang et al.
Blood, 105(3), 1127-1134 (2004-09-24)
G2A is a G-protein-coupled receptor (GPCR) involved in immune regulation. Previous studies have shown that lysophosphatidylcholine (LPC), a bioactive lipid associated with atherosclerosis and autoimmunity, acts through G2A to induce diverse biologic effects. Production of LPC during cell apoptosis serves
Yoko Shima et al.
The Journal of biological chemistry, 295(20), 6983-6991 (2020-04-10)
Newly synthesized major histocompatibility complex (MHC) class I proteins are stabilized in the endoplasmic reticulum (ER) by binding 8-10-mer-long self-peptide antigens that are provided by transporter associated with antigen processing (TAP). These MHC class I:peptide complexes then exit the ER
Caius G Radu et al.
Proceedings of the National Academy of Sciences of the United States of America, 101(1), 245-250 (2003-12-19)
G2A is an immunoregulatory G protein-coupled receptor predominantly expressed in lymphocytes and macrophages. Ectopic overexpression studies have implicated G2A as a receptor for the bioactive lysophospholipid, lysophosphatidylcholine (LPC). However, the functional consequences of LPC-G2A interaction at physiological levels of receptor

資料

The critical micelle concentration (CMC) can be approximately defined as the lipid monomer concentration at which appreciable amounts (>5% of total) of micellar aggregates first begin to appear in the equilibrium: nM1<=>Mn

ライフサイエンス、有機合成、材料科学、クロマトグラフィー、分析など、あらゆる分野の研究に経験のあるメンバーがおります。.

テクニカルサービス連絡先